Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 64.58%6.9M | 65.44%3.05M | -29.04%43.7M | 49.04%23.35M | 15.80%13.85M | -64.26%4.19M | -91.70%1.85M | 0.29%61.59M | -3.68%15.67M | -20.29%11.96M |
| Cost of revenue | 116.35%5.86M | 85.82%2.54M | -25.24%32.85M | 110.76%20.1M | 6.72%7.38M | -74.46%2.71M | -91.89%1.37M | -8.45%43.94M | -28.84%9.54M | -38.22%6.92M |
| Gross profit | -30.09%1.04M | 7.11%512K | -38.50%10.85M | -47.00%3.25M | 28.25%6.46M | 32.56%1.48M | -91.08%478K | 31.60%17.65M | 114.04%6.13M | 32.46%5.04M |
| Operating expense | 37.79%5.09M | 105.13%2.08M | -33.70%17.19M | -51.65%2.47M | 4.33%3.32M | 20.21%3.69M | -60.27%1.01M | 66.52%25.93M | -9.28%5.1M | -15.86%3.18M |
| Selling and administrative expenses | 19.21%4.07M | -11.23%2.48M | -33.70%17.19M | -5.62%4.52M | 5.63%3.04M | 23.29%3.42M | 7.78%2.8M | 66.52%25.93M | -26.91%4.78M | -17.17%2.88M |
| -General and administrative expense | 19.21%4.07M | -11.23%2.48M | -33.70%17.19M | -5.62%4.52M | 5.63%3.04M | 23.29%3.42M | 7.78%2.8M | 66.52%25.93M | -26.91%4.78M | -17.17%2.88M |
| Depreciation and amortization | -1.99%246K | ---- | ---- | -20.66%242K | -18.75%247K | -17.16%251K | ---- | ---- | --305K | -0.98%304K |
| -Depreciation | -1.99%246K | ---- | ---- | -20.66%242K | -18.75%247K | -17.16%251K | ---- | ---- | --305K | -0.98%304K |
| Other operating expenses | 2,660.71%773K | ---- | ---- | -15,360.00%-2.29M | --33K | --28K | ---- | ---- | --15K | ---- |
| Total other operating income | ---- | -77.40%403K | ---- | ---- | ---- | ---- | 4,046.51%1.78M | ---- | ---- | ---- |
| Operating profit | -83.27%-4.05M | -192.54%-1.57M | 23.47%-6.34M | -23.88%781K | 69.29%3.14M | -13.15%-2.21M | -119.12%-536K | -282.77%-8.29M | 137.15%1.03M | 8,738.10%1.86M |
| Net non-operating interest income (expenses) | -5.13%-4.3M | 42.07%-4.71M | -31.55%-21.92M | 0.34%-5.24M | -8.92%-4.45M | -22.03%-4.09M | -104.84%-8.12M | 1.60%-16.66M | 11.70%-5.26M | -43.08%-4.08M |
| Non-operating interest income | -37.09%268K | 42.72%588K | 1.45%1.75M | 423.77%858K | -10.73%416K | -52.35%426K | -59.69%412K | -8.68%1.73M | -162.50%-265K | 11.22%466K |
| Non-operating interest expense | -7.63%4.94M | -37.98%5.29M | 8.81%21.95M | 15.97%6.1M | 4.83%5.23M | 7.24%5.35M | 71.12%8.53M | 9.51%20.18M | 35.72%5.26M | 10.44%4.99M |
| Total other finance cost | 55.56%-368K | ---- | 195.64%1.71M | ---- | 16.44%-371K | -12.20%-828K | ---- | -551.13%-1.79M | -108.70%-218K | 64.42%-444K |
| Net investment income | 37K | |||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | |||||||||
| Income from associates and other participating interests | -58.71%-246K | -101.87%-90K | 737.94%4.34M | -6.17%-172K | 4.94%-154K | 17.99%-155K | 2,985.63%4.82M | 46.71%-680K | 86.76%-162K | -752.63%-162K |
| Special income (charges) | 3,950.00%567K | -872.53%-1.41M | 110.87%579K | -2,957.84%-2.92M | -93.00%14K | -76.49%182K | -53,150.00%-5.33M | -86.99%102K | ||
| Less:Restructuring and mergern&acquisition | ---- | ---- | --3.86M | --0 | ---- | ---- | ---- | --0 | ---322K | ---- |
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --114K | ---- |
| Less:Other special charges | ---124K | ---- | ---- | ---- | 990.99%3.51M | ---- | ---- | ---- | ---- | --322K |
| Less:Write off | -3,064.29%-443K | ---- | 872.53%1.41M | -110.46%-579K | -41.04%-598K | 93.00%-14K | ---- | 76.49%-182K | 55,230.00%5.53M | 45.92%-424K |
| Other non-operating income (expenses) | 64.17%-67K | -41.84%-478K | 605.33%12.6M | 183.58%7.13M | 3,950.00%154K | 83.87%-187K | 41.19%-337K | -151.98%-2.49M | -255.18%-8.53M | 33.33%-4K |
| Income before tax | -22.16%-8.1M | -63.82%-6.84M | 54.46%-12.72M | 117.07%3.12M | -84.24%-4.22M | -20.67%-6.63M | -119.67%-4.18M | -80.54%-27.94M | -286.94%-18.25M | -10.47%-2.29M |
| Income tax | 175.00%11K | 33.33%4K | 97.14%69K | -233.33%-8K | 6,500.00%64K | -20.00%4K | -88.00%3K | -40.68%35K | -79.31%6K | -106.67%-1K |
| Net income | -22.25%-8.11M | -63.80%-6.85M | 54.27%-12.79M | 117.10%3.12M | -87.11%-4.28M | -20.63%-6.64M | -116.98%-4.18M | -80.08%-27.97M | -284.70%-18.26M | -9.63%-2.29M |
| Net income continuous operations | -22.25%-8.11M | -63.80%-6.85M | 54.27%-12.79M | 117.10%3.12M | -87.11%-4.28M | -20.63%-6.64M | -116.98%-4.18M | -80.08%-27.97M | -284.70%-18.26M | -9.63%-2.29M |
| Net income discontinuous operations | ---- | ---- | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Noncontrolling interests | -120.00%-1K | 0 | 75.61%-20K | 25.00%-3K | 75.86%-7K | -93.51%5K | 88.10%-15K | 35.43%-82K | 89.47%-4K | 3.33%-29K |
| Net income attributable to the company | -22.15%-8.11M | -64.39%-6.85M | 54.21%-12.77M | 117.13%3.13M | -89.20%-4.28M | -19.05%-6.64M | -131.33%-4.16M | -81.03%-27.89M | -287.72%-18.25M | -9.82%-2.26M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -22.15%-8.11M | -64.39%-6.85M | 54.21%-12.77M | 117.13%3.13M | -89.20%-4.28M | -19.05%-6.64M | -131.33%-4.16M | -81.03%-27.89M | -287.72%-18.25M | -9.82%-2.26M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -406.67%-0.0076 | -620.00%-0.0072 | 54.29%-0.016 | 118.60%0.0008 | -80.00%-0.0045 | 76.92%-0.0015 | 50.00%-0.001 | -94.44%-0.035 | 21.82%-0.0043 | 0.00%-0.0025 |
| Diluted earnings per share | -406.67%-0.0076 | -620.00%-0.0072 | 54.29%-0.016 | 118.60%0.0008 | -80.00%-0.0045 | 76.92%-0.0015 | 50.00%-0.001 | -94.44%-0.035 | 21.82%-0.0043 | 0.00%-0.0025 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.